Detalhe da pesquisa
1.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Lancet
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763154
2.
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Lancet Oncol
; 24(5): 443-456, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142371
3.
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Lancet
; 399(10323): 447-460, 2022 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953525
4.
TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer.
BJU Int
; 2022 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35908256
5.
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.
Lancet
; 396(10260): 1413-1421, 2020 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002429
6.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med
; 377(4): 338-351, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28578639
7.
Urine DNA for monitoring chemoradiotherapy response in muscle-invasive bladder cancer: a pilot study.
BJU Int
; 129(1): 32-34, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34491610
8.
Outcomes following external beam radiotherapy to the prostate and pelvic lymph nodes in addition to androgen deprivation therapy in non-metastatic prostate adenocarcinoma with regional lymph node involvement: a retrospective cohort study.
BJR Open
; 5(1): 20220030, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37035766
9.
First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer.
BJUI Compass
; 4(4): 464-472, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334027
10.
Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer.
BJUI Compass
; 3(6): 484-493, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36267204
11.
A Study of Pazopanib Safety and Efficacy in Patients With Advanced Clear Cell Renal Cell Carcinoma and ECOG Performance Status 2 (Pazo2): An Open label, Multicentre, Single Arm, Phase II Trial.
Clin Genitourin Cancer
; 20(5): 473-481, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803859
12.
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.
JNCI Cancer Spectr
; 6(4)2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877084
13.
The PD-1/PD-L1 axis in the pathogenesis of urothelial bladder cancer and evaluating its potential as a therapeutic target.
Future Oncol
; 12(5): 595-600, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26880382
14.
Feasibility randomised controlled trial of a guided workbook intervention to support work-related goals among cancer survivors in the UK.
BMJ Open
; 9(1): e022746, 2019 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30670507
15.
Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL).
Int J Radiat Oncol Biol Phys
; 103(3): 605-617, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30528653
16.
Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: Birmingham experience.
Oncol Rep
; 20(4): 891-6, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18813832
17.
Interstitial lung disease secondary to Cetuximab in bladder cancer: an Oncologist's perspective.
BMJ Case Rep
; 20172017 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29269357
18.
Usefulness and engagement with a guided workbook intervention (WorkPlan) to support work related goals among cancer survivors.
BMC Psychol
; 5(1): 34, 2017 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28978353
19.
A Guided Workbook Intervention (WorkPlan) to Support Work-Related Goals Among Cancer Survivors: Protocol of a Feasibility Randomized Controlled Trial.
JMIR Res Protoc
; 5(2): e75, 2016 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27143229
20.
Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy.
Int J Radiat Oncol Biol Phys
; 92(4): 874-83, 2015 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26104940